Gene therapy of the ischemic lower limb - Therapeutic angiogenesis

Vascular Pharmacology

Volumn 44, Issue 6, 2006, Pages 395-405

  Bobek, Vladimir ^a,b   Taltynov, Oliver ^c   Pinterova, Daniela ^a   Kolostova, Katarina ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

PAOD; Plasmid; Therapeutic angiogenesis; Vector; VEGF

Indexed keywords

ALPHA INTERFERON; ANGIOERRESTIN; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOSTATIN; ANTITHROMBIN III; BETA INTERFERON; CARTILAGE DERIVED INHIBITOR; CHORIONIC GONADOTROPIN; ENDOSTATIN; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRO BETA; GROWTH FACTOR; HEPARIN LYASE; INTERLEUKIN 12; LIPOSOME; METALLOPROTEINASE INHIBITOR; PLASMID DNA; PLASMINOGEN ACTIVATOR INHIBITOR; RECOMBINANT GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN A; VIRUS VECTOR;

ANGIOGENESIS; ATHEROSCLEROSIS; CLINICAL TRIAL; DNA VECTOR; DRUG EFFECT; DRUG INHIBITION; EDEMA; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; GRAFT FAILURE; HUMAN; LEG ISCHEMIA; LYMPHEDEMA; METASTASIS; NONHUMAN; PERIPHERAL EDEMA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLASMID; PRIORITY JOURNAL; PROTEINURIA; RESTENOSIS; RETINOPATHY; REVIEW; THROMBOCYTOPENIA;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; CLINICAL TRIALS; ENDOTHELIAL CELLS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; ISCHEMIA; LOWER EXTREMITY; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 33646785031     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.03.009     Document Type: Review

References (147)

1. Akeno N., Robins J., Zhang M., Czyzyk-Krzeska M.F., and Clemens T.L. Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha. Endocrinology 143 2 (2002) 420-425
2. Aoki M., Morishita R., Taniyama Y., Kida I., Moriguchi A., Matsumoto K., et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis. Gene Ther. 7 5 (2000) 417-427
3. Arras M., Ito W.D., Scholz D., Winkler B., Schaper J., and Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101 1 (1998) 40-50
4. Asahara T., Chen D., Tsurumi Y., Kearney M., Rossow S., Passeri J., et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 94 12 (1996) 3291-3302
5. Asahara T., Murohara T., Sullivan A., Silver M., van der Z.R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 5302 (1997) 964-967
6. Asahara T., Chen D., Takahashi T., Fujikawa K., Kearney M., Magner M., et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83 3 (1998) 233-240
7. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85 3 (1999) 221-228
8. Baumgartner I., Pieczek A., Manor O., Blair R., Kearney M., Walsh K., et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97 12 (1998) 1114-1123
9. Baumgartner I., Rauh G., Pieczek A., Wuensch D., Magner M., Kearney M., et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann. Intern. Med. 132 11 (2000) 880-884
10. Bauters C., Asahara T., Zheng L.P., Takeshita S., Bunting S., Ferrara N., et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21 2 (1995) 314-324
11. Bermont L., Lamielle F., Fauconnet S., Esumi H., Weisz A., and Adessi G.L. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells. Int. J. Cancer 85 1 (2000) 117-123
12. Castellon R., Hamdi H.K., Sacerio I., Aoki A.M., Kenney M.C., and Ljubimov A.V. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp. Eye Res. 74 4 (2002) 523-535
13. Celec P., Gardlik R., Palffy R., Hodosy J., Stuchlik S., Drahovska H., et al. The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor - an alternative gene therapy. Med. Hypotheses 64 3 (2005) 505-511
14. Chae J.K., Kim I., Lim S.T., Chung M.J., Kim W.H., Kim H.G., et al. Co-administration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler. Thromb. Vasc. Biol. 20 12 (2000) 2573-2578
15. Cheng H.L., Randolph A., Yee D., Delafontaine P., Tennekoon G., and Feldman E.L. Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. J. Neurochem. 66 2 (1996) 525-536
16. Compernolle V., Brusselmans K., Acker T., Hoet P., Tjwa M., Beck H., et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 8 7 (2002) 702-710
17. Conklin L.D., McAninch R.E., Schulz D., Kaluza G.L., LeMaire S.A., Coselli J.S., et al. HIV-based vectors and angiogenesis following rabbit hindlimb ischemia. J. Surg. Res. 123 1 (2005) 55-66
18. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., and Isner J.M. Mouse model of angiogenesis. Am. J. Pathol. 152 6 (1998) 1667-1679
19. Couffinhal T., Silver M., Kearney M., Sullivan A., Witzenbichler B., Magner M., et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/-mice. Circulation 99 24 (1999) 3188-3198
20. Davis H.L., Whalen R.G., and Demeneix B.A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4 2 (1993) 151-159
21. Demeneix B.A., Abdel-Taweb H., Benoist C., Seugnet I., and Behr J.P. Temporal and spatial expression of lipospermine-compacted genes transferred into chick embryos in vivo. Biotechniques 16 3 (1994) 496-501
22. Dor Y., Porat R., and Keshet E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am. J. Physiol., Cell Physiol. 280 6 (2001) C1367-C1374
23. Dor Y., Djonov V., Abramovitch R., Itin A., Fishman G.I., Carmeliet P., et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 21 8 (2002) 1939-1947
24. Dormandy J.A., and Thomas P.R. What is the natural history of a critically ischemic patient with and without his leg?. In: Greenhalgh R.M.J.C.N.A.N. (Ed). Limb Salvage and Amputation for Vascular Disease. [11th ed. Philadelphia] (1988), WB Saunders 11-26
25. Dormandy J., Mahir M., Ascady G., Balsano F., De Leeuw P., Blombery P., et al. Fate of the patient with chronic leg ischaemia. A review article. J. Cardiovasc. Surg. (Torino) 30 1 (1989) 50-57
26. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146 5 (1995) 1029-1039
27. Dvorak H.F., Nagy J.A., Feng D., Brown L.F., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237 (1999) 97-132
28. Feldman L.J., Steg P.G., Zheng L.P., Chen D., Kearney M., McGarr S.E., et al. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J. Clin. Invest. 95 6 (1995) 2662-2671
29. Ferrara N., and Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5 12 (1999) 1359-1364
30. Ferrara N., and Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161 2 (1989) 851-858
31. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 6 (2003) 669-676
32. Fiorelli G., Formigli L., Zecchi O.S., Gori F., Falchetti A., Morelli A., et al. Characterization and function of the receptor for IGF-I in human preosteoclastic cells. Bone 18 3 (1996) 269-276
33. Fitzgerald P.J., Ports T.A., and Yock P.G. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 86 1 (1992) 64-70
34. Folkman J. Therapeutic angiogenesis in ischemic limbs. Circulation 97 12 (1998) 1108-1110
35. Gabrilovich D.I., Chen H.L., Girgis K.R., Cunningham H.T., Meny G.M., Nadaf S., et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2 10 (1996) 1096-1103
36. Galzie Z., Kinsella A.R., and Smith J.A. Fibroblast growth factors and their receptors. Biochem. Cell. Biol. 75 6 (1997) 669-685
37. Garcia-Martinez C., Opolon P., Trochon V., Chianale C., Musset K., Lu H., et al. Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factor. Gene Ther. 6 7 (1999) 1210-1221
38. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., and Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5 6 (1999) 623-628
39. Gregg R.O. Bypass or amputation? Concomitant review of bypass arterial grafting and major amputations. Am. J. Surg. 149 3 (1985) 397-402
40. Grines C.L., Watkins M.W., Helmer G., Penny W., Brinker J., Marmur J.D., et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105 11 (2002) 1291-1297
41. Harris J.D., and Lemoine N.R. Strategies for targeted gene therapy. Trends Genet. 12 10 (1996) 400-405
42. Hasson E., Arbel D., Verstandig A., Shimoni Y., and Mitrani E. A cell-based multifactorial approach to angiogenesis. J. Vasc. Res. 42 1 (2005) 29-37
43. Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193 9 (2001) 1005-1014
44. Hedin U., and Wahlberg E. Gene therapy and vascular disease: potential applications in vascular surgery. Eur. J. Vasc. Endovasc. Surg. 13 2 (1997) 101-111
45. Hedman M., Hartikainen J., Syvanne M., Stjernvall J., Hedman A., Kivela A., et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107 21 (2003) 2677-2683
46. Hiltunen M.O., Laitinen M., Turunen M.P., Jeltsch M., Hartikainen J., Rissanen T.T., et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102 18 (2000) 2262-2268
47. Hiltunen M.O., Turunen M.P., Turunen A.M., Rissanen T.T., Laitinen M., Kosma V.M., et al. Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods. FASEB J. 14 14 (2000) 2230-2236
48. Houck K.A., Leung D.W., Rowland A.M., Winer J., and Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267 36 (1992) 26031-26037
49. Isner J.M. Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results. Adv. Drug Deliv. Rev. 30 1-3 (1998) 185-197
50. Isner J.M., and Rosenfield K. Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization. Circulation 88 4 Pt 1 (1993) 1534-1557
51. Isner J.M., Pieczek A., Schainfeld R., Blair R., Haley L., Asahara T., et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348 9024 (1996) 370-374
52. Isner J.M., Baumgartner I., Rauh G., Schainfeld R., Blair R., Manor O., et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J. Vasc. Surg. 28 6 (1998) 964-973
53. Isner J.M., Vale P.R., Symes J.F., and Losordo D.W. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ. Res. 89 5 (2001) 389-400
54. Jiang H., Zhang T., and Sun X. Vascular endothelial growth factor gene delivery by magnetic DNA nanospheres ameliorates limb ischemia in rabbits (1). J. Surg. Res. 126 1 (2005) 48-54
55. Kibbe M.R., Murdock A., Wickham T., Lizonova A., Kovesdi I., Nie S., et al. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors. Arch. Surg. 135 2 (2000) 191-197
56. Kim H.J., Jang S.Y., Park J.I., Byun J., Kim D.I., Do Y.S., et al. Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease. Exp. Mol. Med. 36 4 (2004) 336-344
57. Kobayashi T., and Kamata K. Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats. Am. J. Physiol, Heart Circ. Physiol. 283 5 (2002) H1761-H1768
58. Ku D.D., Zaleski J.K., Liu S., and Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265 2 Pt 2 (1993) H586-H592
59. Kuo M.D., Waugh J.M., Yuksel E., Weinfeld A.B., Yuksel M., Dake M.D., and American Roentgen Ray Society. ARRS President's Award. The potential of in vivo vascular tissue engineering for the treatment of vascular thrombosis: a preliminary report. A.J.R. Am. J. Roentgenol. 171 3 (1998) 553-558
60. Kupfer J.M., Ruan X.M., Liu G., Matloff J., Forrester J., and Chaux A. High efficiency gene transfer to autologous rabbit jugular vein grafts using adenovirus-transferrin/polylysine-DNA complexes. Hum. Gene Ther. 5 12 (1994) 1437-1443
61. Laitinen M., Makinen K., Manninen H., Matsi P., Kossila M., Agrawal R.S., et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum. Gene Ther. 9 10 (1998) 1481-1486
62. Laitinen M., Hartikainen J., Hiltunen M.O., Eranen J., Kiviniemi M., Narvanen O., et al. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum. Gene Ther. 11 2 (2000) 263-270
63. Lawrie A., Brisken A.F., Francis S.E., Cumberland D.C., Crossman D.C., and Newman C.M. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther. 7 23 (2000) 2023-2027
64. Legendre J.Y., and Szoka Jr. FC. Cyclic amphipathic peptide-DNA complexes mediate high-efficiency transfection of adherent mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 90 3 (1993) 893-897
65. Li J., Post M., Volk R., Gao Y., Li M., Metais C., et al. PR39, a peptide regulator of angiogenesis. Nat. Med. 6 1 (2000) 49-55
66. Mack C.A., Magovern C.J., Budenbender K.T., Patel S.R., Schwarz E.A., Zanzonico P., et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J. Vasc. Surg. 27 4 (1998) 699-709
67. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., and Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. U. S. A. 88 20 (1991) 9267-9271
68. Makinen K.L., Laitinen M., Manninen M., Matsi P., Alhava P., and Yla-Hertualla S. Catheter-mediated VEGF gene transfer to human lower limb arteries after PTA (abstract). Circulation 100 (1999) 4064
69. Makinen K., Manninen H., Hedman M., Matsi P., Mussalo H., Alhava E., et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Molec. Ther. 6 1 (2002) 127-133
70. Malecki M., Przybyszewska M., and Janik P. Construction of a bicistronic proangiogenic expression vector and its application in experimental angiogenesis in vivo. Acta Biochim. Pol. 50 3 (2003) 875-882
71. Mann M.J. Gene therapy for peripheral arterial disease. Mol. Med. Today 6 7 (2000) 285-291
72. Mann M.J., Gibbons G.H., Kernoff R.S., Diet F.P., Tsao P.S., Cooke J.P., et al. Genetic engineering of vein grafts resistant to atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 92 10 (1995) 4502-4506
73. Mann M.J., Whittemore A.D., Donaldson M.C., Belkin M., Conte M.S., Polak J.F., et al. Ex vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 354 9189 (1999) 1493-1498
74. Matsumoto T., and Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001 112 (2001) RE21
75. Matsumoto R., Omura T., Yoshiyama M., Hayashi T., Inamoto S., Koh K.R., et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 25 6 (2005) 1168-1173
76. Maxwell P.H., and Ratcliffe P.J. Oxygen sensors and angiogenesis. Semin. Cell Dev. Biol. 13 1 (2002) 29-37
77. Menetrey J., Kasemkijwattana C., Day C.S., Bosch P., Vogt M., Fu F.H., et al. Growth factors improve muscle healing in vivo. J. Bone Jt. Surg., Br. 82 1 (2000) 131-137
78. Miele C., Rochford J.J., Filippa N., Giorgetti-Peraldi S., and Van Obberghen E. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J. Biol. Chem. 275 28 (2000) 21695-21702
79. Monahan P.E., and Samulski R.J. AAV vectors: is clinical success on the horizon?. Gene Ther. 7 1 (2000) 24-30
80. Morishita R. Recent progress in gene therapy for cardiovascular disease. Circ. J. 66 12 (2002) 1077-1086
81. Morishita R., Nakamura S., Hayashi S., Taniyama Y., Moriguchi A., Nagano T., et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33 6 (1999) 1379-1384
82. Nakamura T., Mizuno S., Matsumoto K., Sawa Y., Matsuda H., and Nakamura T. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J. Clin. Invest. 106 12 (2000) 1511-1519
83. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., et al. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272 5259 (1996) 263-267
84. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13 1 (1999) 9-22
85. Ng Y.S., and D'Amore P.A. Therapeutic angiogenesis for cardiovascular disease. Curr. Control. Trials, Cardiovasc. Med. 2 6 (2001) 278-285
86. Ninomiya M., Koyama H., Miyata T., Hamada H., Miyatake S., Shigematsu H., et al. Ex vivo gene transfer of basic fibroblast growth factor improves cardiac function and blood flow in a swine chronic myocardial ischemia model. Gene Ther. 10 14 (2003) 1152-1160
87. Nishida T., Ueno H., Atsuchi N., Kawano R., Asada Y., Nakahara Y., et al. Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit. Circ. Res. 84 12 (1999) 1446-1452
88. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., and Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 274 22 (1999) 15732-15739
89. Ohara N., Koyama H., Miyata T., Hamada H., Miyatake S.I., Akimoto M., et al. Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia. Gene Ther. 8 11 (2001) 837-845
90. Ouriel K., Fiore W.M., and Geary J.E. Limb-threatening ischemia in the medically compromised patient: amputation or revascularization?. Surgery 104 4 (1988) 667-672
91. Pu L.Q., Sniderman A.D., Brassard R., Lachapelle K.J., Graham A.M., Lisbona R., et al. Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation 88 1 (1993) 208-215
92. Punglia R.S., Lu M., Hsu J., Kuroki M., Tolentino M.J., Keough K., et al. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 46 10 (1997) 1619-1626
93. Puyal C., Milhaud P., Bienvenue A., and Philippot J.R. A new cationic liposome encapsulating genetic material. A potential delivery system for polynucleotides. Eur. J. Biochem. 228 3 (1995) 697-703
94. Rabinovsky E.D., and Draghia-Akli R. Insulin-like growth factor I plasmid therapy promotes in vivo angiogenesis. Molec. Ther. 9 1 (2004) 46-55
95. Rade J.J., Schulick A.H., Virmani R., and Dichek D.A. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat. Med. 2 3 (1996) 293-298
96. Rajagopalan S., Shah M., Luciano A., Crystal R., and Nabel E.G. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation 104 7 (2001) 753-755
97. Reinmuth N., Fan F., Liu W., Parikh A.A., Stoeltzing O., Jung YD., et al. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab. Invest. 82 10 (2002) 1377-1389
98. Remy J.S., Sirlin C., Vierling P., and Behr J.P. Gene transfer with a series of lipophilic DNA-binding molecules. Bioconjug. Chem. 5 6 (1994) 647-654
99. Riesbeck K., Chen D., Kemball-Cook G., McVey J.H., George A.J., Tuddenham E.G., et al. Expression of hirudin fusion proteins in mammalian cells: a strategy for prevention of intravascular thrombosis. Circulation 98 24 (1998) 2744-2752
100. Rissanen T.T., Vajanto I., and Yla-Herttuala S. Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic. Eur. J. Clin. Investig. 31 8 (2001) 651-666
101. Rissanen T.T., Markkanen J.E., Arve K., Rutanen J., Kettunen M.I., Vajanto I., et al. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J. 17 1 (2003) 100-102
102. Roberts W.G., and Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108 Pt 6 (1995) 2369-2379
103. Saaristo A., Veikkola T., Tammela T., Enholm B., Karkkainen M.J., Pajusola K., et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 196 6 (2002) 719-730
104. Safran M., and Kaelin Jr. W.G. HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Invest. 111 6 (2003) 779-783
105. Schaper W., and Scholz D. Factors regulating arteriogenesis. Arterioscler. Thromb. Vasc. Biol. 23 7 (2003) 1143-1151
106. Second European Consensus Document on chronic critical leg ischaemia. Circulation 84 (2004) IV1-26 (suppl.)
107. Semenza G.L. HIF-1 and human disease: one highly involved factor. Genes Dev. 14 16 (2000) 1983-1991
108. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 2 (1998) 362-367
109. Shigematsu S., Yamauchi K., Nakajima K., Iijima S., Aizawa T., and Hashizume K. IGF-1 regulates migration and angiogenesis of human endothelial cells. Endocr. J. 46 (1999) S59-S62 (Suppl)
110. Shyu K.G., Manor O., Magner M., Yancopoulos G.D., and Isner J.M. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 98 19 (1998) 2081-2087
111. Shyu K.G., Chang H., Wang B.W., and Kuan P. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am. J. Med. 114 2 (2003) 85-92
112. Simberg D., Danino D., Talmon Y., Minsky A., Ferrari M.E., Wheeler C.J., et al. Phase behavior, DNA ordering, and size instability of cationic lipoplexes. Relevance to optimal transfection activity. J. Biol. Chem. 276 50 (2001) 47453-47459
113. Spoerri P.E., Ellis E.A., Tarnuzzer R.W., and Grant M.B. Insulin-like growth factor: receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin. Growth Horm. IGF Res. 8 2 (1998) 125-132
114. Springer M.L., Chen A.S., Kraft P.E., Bednarski M., and Blau H.M. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol. Cell 2 5 (1998) 549-558
115. Springer M.L., Hortelano G., Bouley D.M., Wong J., Kraft P.E., and Blau H.M. Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor. J. Gene Med. 2 4 (2000) 279-288
116. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 282 5388 (1998) 468-471
117. Svensson E.C., Marshall D.J., Woodard K., Lin H., Jiang F., Chu L., et al. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 99 2 (1999) 201-205
118. Takeshita S., and Isner J.M. Peripheral angiogenesis: therapeutic angiogenesis for peripheral vascular occlusive disease. Curr. Interv. Cardiol. Rep. 1 2 (1999) 147-156
119. Takeshita S., Pu L.Q., Stein L.A., Sniderman A.D., Bunting S., Ferrara N., et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90 5 Pt 2 (1994) II228-II234
120. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., et al. Therapeutic angiogenesis. A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93 2 (1994) 662-670
121. Takeshita S., Isshiki T., and Sato T. Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats. Lab. Invest. 74 6 (1996) 1061-1065
122. Takeshita S., Isshiki T., Ochiai M., Eto K., Mori H., Tanaka E., et al. Endothelium-dependent relaxation of collateral micro-vessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 98 13 (1998) 1261-1263
123. Taniyama Y., Tachibana K., Hiraoka K., Aoki M., Yamamoto S., Matsumoto K., et al. Development of safe and efficient novel non-viral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 9 6 (2002) 372-380
124. Teiger E., Deprez I., Fataccioli V., Champagne S., Dubois-Rande J.L., Eloit M., et al. Gene therapy in heart disease. Biomed. Pharmacother. 55 3 (2001) 148-154
125. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 5449 (1999) 2511-2514
126. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6 4 (2000) 460-463
127. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266 18 (1991) 11947-11954
128. Tomlinson E.R.A. Controllable gene therapy: pharmaceutics of non-viral gene delivery systems. J. Control. Release 39 (1996) 357-372
129. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 7 1 (2000) 20-23
130. Tsurumi Y., Takeshita S., Chen D., Kearney M., Rossow S.T., Passeri J., et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94 12 (1996) 3281-3290
131. Van Belle E., Witzenbichler B., Chen D., Silver M., Chang L., Schwall R., et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 97 4 (1998) 381-390
132. Vitadello M., Schiaffino M.V., Picard A., Scarpa M., and Schiaffino S. Gene transfer in regenerating muscle. Hum. Gene Ther. 5 1 (1994) 11-18
133. Walsh M.F., Barazi M., Pete G., Muniyappa R., Dunbar J.C., and Sowers J.R. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 137 5 (1996) 1798-1803
134. Waugh J.M., Kattash M., Li J., Yuksel E., Kuo M.D., Lussier M., et al. Gene therapy to promote thromboresistance: local overexpression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model. Proc. Natl. Acad. Sci. U. S. A. 96 3 (1999) 1065-1070
135. Waugh J.M., Yuksel E., Li J., Kuo M.D., Kattash M., Saxena R., et al. Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. Circ. Res. 84 1 (1999) 84-92
136. Wickham T.J. Targeting adenovirus. Gene Ther. 7 2 (2000) 110-114
137. Willard J.E., Landau C., Glamann D.B., Burns D., Jessen M.E., Pirwitz M.J., et al. Genetic modification of the vessel wall. Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation 89 5 (1994) 2190-2197
138. Wolff J.A., Williams P., Acsadi G., Jiao S., Jani A., and Chong W. Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques 11 4 (1991) 474-485
139. Wright M.J., Wightman L.M., Latchman D.S., and Marber M.S. In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther. 8 24 (2001) 1833-1839
140. Wu Y., Yakar S., Zhao L., Hennighausen L., and LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res. 62 4 (2002) 1030-1035
141. Yamamoto K., Morishita R., Tomita N., Shimozato T., Nakagami H., Kikuchi A., et al. Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease. Circulation 102 11 (2000) 1308-1314
142. Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408 6808 (2000) 92-96
143. Yla-Herttuala S., and Martin J.F. Cardiovascular gene therapy. Lancet 355 9199 (2000) 213-222
144. Yoon Y.S., Murayama T., Gravereaux E., Tkebuchava T., Silver M., Curry C., et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J. Clin. Invest. 111 5 (2003) 717-725
145. Yoon Y.S., Johnson I.A., Park J.S., Diaz L., and Losordo D.W. Therapeutic myocardial angiogenesis with vascular endothelial growth factors. Mol. Cell. Biochem. 264 1-2 (2004) 63-74
146. Zoldhelyi P., McNatt J., Xu X.M., Loose-Mitchell D., Meidell R.S., Clubb Jr. F.J., et al. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Circulation 93 1 (1996) 10-17
147. Zoldhelyi P., McNatt J., Shelat H.S., Yamamoto Y., Chen Z.Q., and Willerson J.T. Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor. Circulation 101 3 (2000) 289-295